Current Edition

Upcoming Events

Advertisement

news

Daiichi acquires another ADC drug through Glycotope licensing deal

Daiichi Sankyo is bringing a seventh antibody-drug conjugate, or ADC, into its pipeline through a licensing agreement with German biotech Glycotope. Specific fin...
Continue Reading →
news

WuXi Biologics Initiates Construction of a Integrated ADC Solution Center in China

This $20 million 6,000 square meter facility will be operational in 2019 and provide integrated solutions from concept to commercialization for biologics conjugates...
Continue Reading →